Yellow nail syndrome associated with thiol compound therapy for rheumatoid arthritis. Two case reports.
Yellow nail syndrome is characterized by ungual dystrophy, lower limb lymphedema, and pleural effusions or bronchiectasis. Rheumatoid arthritis is the autoimmune disorder most often associated with yellow nail syndrome. We report two new cases of yellow nail syndrome in patents receiving thiol compound therapy for rheumatoid arthritis. Eight similar cases have been reported since 1979, suggesting a possible causative effect of this class of drugs.
Rheumatology department, CHU Jean-Minjoz, Besançon, France.
Gaëlle
G
Lehuédé
Eric
E
Toussirot
Jacques
J
Despaux
Fabrice
F
Michel
Daniel
D
Wendling
D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009260:Nail Diseases / Q000139:chemically induced*; D010396:Penicillamine / Q000009:adverse effects*; D008625:Tiopronin / Q000009:adverse effects*
D018501:Antirheumatic Agents; D008625:Tiopronin; D010396:Penicillamine